BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[Biostar Pharmaceuticals, Inc. Expands Rural Network by Over 21% in Third Quarter 2010; Brings Total Number of Locations to 8,500 XIANYANG, China, Oct 25/PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (Nasdaq:BSPM - News) ("Biostar" or "the Company"), a Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules ("Xin Aoxing Capsules"), and a variety of pharmaceutical products, today]

By | 2016-03-03T13:52:21+00:00 October 25th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals,] 8-K: Biostar Pharmaceuticals, Inc. Expands Rural Network by Over

[Biostar Pharmaceuticals, Inc. Expands Rural Network by Over 21% in Third Quarter 2010; Brings Total Number of Locations to 8,500 XIANYANG, China, Oct 25/PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (Nasdaq:BSPM - News) ("Biostar" or "the Company"), a Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules ("Xin Aoxing Capsules"), and a variety of pharmaceutical products, today]

By | 2016-03-03T13:53:49+00:00 October 25th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations Press Release Source: Sinovac Biotech Ltd. On Sunday October 24, 2010, 5:00 pm BEIJING, Oct. 24 /PRNewswire-Asia-FirstCall/ — Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today its preliminary unaudited sales range for the third quarter ended] [Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens Press Release Source: Sinovac Biotech Ltd. On Sunday October 24, 2010, 5:05 pm BEIJING, Oct. 24 /PRNewswire-Asia-FirstCall/ — Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control] [Sinovac Receives Drug Registration Certificate from Hong Kong Department of Health for Seasonal Flu Vaccine Anflu(R) Press Release Source: Sinovac Biotech Ltd. On Sunday October 24, 2010, 5:10 pm BEIJING, Oct 24 /PRNewswire-Asia-FirstCall/ — Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today that Sinovac Biotech (Hong Kong) Ltd., its wholly owned subsidiary] [1 -32371 SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]

By | 2016-03-24T02:40:30+00:00 October 25th, 2010|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments
Read More

SVA [SINOVAC BIOTECH] 6-K: Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales

[Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations Press Release Source: Sinovac Biotech Ltd. On Sunday October 24, 2010, 5:00 pm BEIJING, Oct. 24 /PRNewswire-Asia-FirstCall/ — Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today its preliminary unaudited sales range for the third quarter ended] [Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens Press Release Source: Sinovac Biotech Ltd. On Sunday October 24, 2010, 5:05 pm BEIJING, Oct. 24 /PRNewswire-Asia-FirstCall/ — Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control] [Sinovac Receives Drug Registration Certificate from Hong Kong Department of Health for Seasonal Flu Vaccine Anflu(R) Press Release Source: Sinovac Biotech Ltd. On Sunday October 24, 2010, 5:10 pm BEIJING, Oct 24 /PRNewswire-Asia-FirstCall/ — Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today that Sinovac Biotech (Hong Kong) Ltd., its wholly owned subsidiary] [1 -32371 SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]

By | 2016-03-24T02:41:58+00:00 October 25th, 2010|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[Biostar Pharmaceuticals, Expands Rural Network by Over 21% in Third Quarter 2010; Brings Total Number of Locations to 8,500 XIANYANG, China, Oct 25/PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, (Nasdaq:BSPM - News) ("Biostar" or "thempany"), a Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acidpsules ("Xin Aoxingpsules"), and a variety of pharmaceutical products, today]

By | 2016-02-07T16:45:30+00:00 October 25th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals,] 8-K: Biostar Pharmaceuticals, Expands Rural Network by Over 21%

[Biostar Pharmaceuticals, Expands Rural Network by Over 21% in Third Quarter 2010; Brings Total Number of Locations to 8,500 XIANYANG, China, Oct 25/PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, (Nasdaq:BSPM - News) ("Biostar" or "thempany"), a Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acidpsules ("Xin Aoxingpsules"), and a variety of pharmaceutical products, today]

By | 2016-02-07T16:46:03+00:00 October 25th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals,] DEF 14A: (Original Filing)

[DEFINITIVE SCHEDULE 14A INFORMATION x o Check the appropriate box: o Preliminary Proxy Statement o x Definitive Proxy Statement o Definitive Additional Materials o BIOSTAR PHARMACEUTICALS, INC. Payment of Filing Fee (Check the appropriate box): x No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.]

By | 2016-03-03T13:55:20+00:00 October 1st, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals,] DEF 14A: DEFINITIVE SCHEDULE 14A INFORMATION x o Check the

[DEFINITIVE SCHEDULE 14A INFORMATION x o Check the appropriate box: o Preliminary Proxy Statement o x Definitive Proxy Statement o Definitive Additional Materials o BIOSTAR PHARMACEUTICALS, INC. Payment of Filing Fee (Check the appropriate box): x No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.]

By | 2016-03-03T13:57:21+00:00 October 1st, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More
Skip to toolbar